We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Genomic Testing Program Improves Diagnosis of Congenital Hyperinsulinism

By LabMedica International staff writers
Posted on 11 May 2026

Congenital hyperinsulinism causes recurrent hypoglycemia in infancy and can lead to brain injury, with neurologic damage affecting about 40% of children with the condition. More...

Differentiating diffuse from focal disease is crucial because focal cases may be surgically curable, yet access to timely genomic testing remains uneven worldwide. Aligning therapy with the underlying genetic cause can also inform surveillance for syndromic presentations. New findings demonstrate a coordinated program that expands rapid genomic testing and documents outcomes across more than 1,100 affected families.

The Open Hyperinsulinism Genes Project is a partnership between the University of Exeter, Royal Devon University Healthcare NHS Foundation Trust, and U.S.-based Congenital Hyperinsulinism International to deliver comprehensive, rapid genomic testing for congenital hyperinsulinism. The program is designed to improve equitable access to genomic medicine for families who cannot obtain testing in their home countries. Exeter provides testing and connects participating families with research opportunities that would otherwise be unavailable to them.

Through genetic analysis, the initiative confirms whether insulin excess arises from the entire pancreas (diffuse disease) or from a localized pancreatic region (focal disease). That distinction guides treatment, as focal disease can be cured by resecting the over-secreting cells, and early surgery reduces the risk of hypoglycemia-related brain injury. Testing also identifies syndromic forms of hyperinsulinism to enable appropriate clinical monitoring.

A correspondence article in Nature Health describes outcomes since the project’s 2018 launch, including funded rapid testing for more than 1,100 families across 63 countries on six continents. The Exeter team delivered a molecular diagnosis for 593 children (52%). Among diagnosed cases, 438 were consistent with diffuse disease and 155 were predicted to have focal disease; a syndromic form of hyperinsulinism was identified in 29 infants.

The collaboration reports that enrolling families from populations underrepresented in genomic studies increases genetic diversity and strengthens the global relevance of resulting discoveries. Project-led research has already deepened understanding of the genetic basis of congenital hyperinsulinism and advanced knowledge of insulin secretion biology and gene regulation. 

“In Exeter, we are committed to ensuring that every child born with congenital hyperinsulinism, wherever they are in the world, can benefit from rapid, state-of-the-art genetic testing, something that has not previously been possible. This project combines Exeter's world-leading genetics expertise with knowledge of the condition ... from Congenital Hyperinsulinism International,” said Sarah Flanagan, professor at the University of Exeter Medical School and lead of the research program.

“This alliance is unlocking access to rapid genomic testing for families across the world, giving children the best chance in life and expanding research to be more inclusive. We believe this model should be expanded to other rare diseases,” said Jayne Houghton, lead clinical scientist for the project at the Royal Devon University Healthcare NHS Foundation Trust.

Related Links
University of Exeter


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Gastrointestinal Panel
Xpert® GI Panel
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Blood Protein Analysis Reveals Menopause-Associated Signals of Brain Aging

Menopause affects women across midlife and is often accompanied by endocrine changes, hot flashes, brain fog and sleep disturbances. Women spend roughly one third of their lives after the menopause transition,... Read more

Hematology

view channel
Image: The newly certified products are the CytoCell ATM Deletion FISH Probe, CytoCell IGH Plus Breakapart FISH Probe, CytoCell IGH/FGFR3 Plus Translocation, Dual Fusion FISH Probe, and CytoCell IGH/MYEOV Plus Translocation, Dual Fusion FISH Probe. (Photo courtesy of OGT)

Newly Certified FISH Probes Support Cytogenetic Testing in Blood Cancers

Hematological malignancies such as non-Hodgkin lymphoma, acute lymphoblastic leukemia, chronic lymphoid leukemia, and multiple myeloma require assessment of key cytogenetic abnormalities.... Read more

Immunology

view channel
Image: Study design and collection of lower respiratory tract lining fluid (RTLF) using the PExA instrument. (Aguilera K, Hober A, Greilert Norin N, et al. eBioMedicine, 2026. doi:10.1016/j.ebiom.2026.106538)

Exhaled Breath Particles Reveal Virus-Specific Antibodies in the Lower Airways

Respiratory viruses such as influenza virus, SARS-CoV-2, and respiratory syncytial virus (RSV) require immune protection across the airway mucosa. Antibodies in the respiratory tract lining are important... Read more

Microbiology

view channel
Image: Four-quadrant streaking of fecal samples on chromogenic UTI agar shows various patterns of relative bacterial species abundance. The assorted shapes of the pinkish colonies indicate different E. coli strains. (Photo courtesy of Sokurenko Lab)

Stool Testing Predicts UTI Risk and Guides Antibiotic Selection

Urinary tract infections (UTIs) are a common reason for antibiotic prescribing in general medical practice and can be painful in postmenopausal women, sometimes progressing to kidney infection or life-threatening... Read more

Pathology

view channel
AI: Artificial intelligence; CNN: Convolutional neural networks; ResNet: Residual neural network. (Xing-hua Gao from The First Hospital of China Medical University, China Image Source Link: https://www.ovid.com/jnls/cmj/fulltext/10.1097/cm9.0000000000004154~deep-learning-based-computational-pathology-technologies)

Review Highlights Progress and Validation Needs for AI in Digital Pathology

Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more

Industry

view channel
Image: The acquisition of Proscia advances Agilent’s efforts to expand its pathology portfolio and strengthens its competitive position in a rapidly growing market.

Agilent Completes Acquisition of Digital Pathology Platform Developer Proscia

Agilent Technologies has completed its acquisition of Proscia, a provider of digital pathology software for clinical and life sciences applications. The transaction involved a cash payment of USD 240 million... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.